MRK Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 22:00):

Stats
Tagesvolumen	4.76M
Durchschnittsvolumen	8.22M
Marktkapitalisierung	324.84B
EPS	$0.0300 ( 2024-04-25 )
Nächstes Ertragsdatum	( $1.870 ) 2024-05-28
Last Dividend	$0.770 ( 2023-12-14 )
Next Dividend	$0 ( N/A )
P/E	142.51
ATR14	$0.0670 (0.05%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Romanelli Joseph	Buy	23 438	Stock Option (Right to Buy)
2024-05-02	Romanelli Joseph	Buy	2 262	Common Stock
2024-05-02	Romanelli Joseph	Sell	1 115	Common Stock
2024-04-30	Romanelli Joseph	Buy	6 191	Restricted Stock Unit
2024-05-02	Romanelli Joseph	Sell	2 262	Restricted Stock Unit

INSIDER POWER
24.31
Last 98 transactions
Buy: 1 344 878 \| Sell: 945 168

Volumen Korrelation

Lang: -0.53 (weak negative)

Kurz: 0.99 (very strong)

Signal:(44.973) Expect same movement, but be aware

Merck & Co Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Merck & Co Inc Korrelation - Währung/Rohstoff

0.53
( weak )

0.52
( weak )

0.00
( neutral )

-0.15
( neutral )

-0.46
( neutral )

-0.27
( neutral )

Merck & Co Inc Finanzdaten

Annual	2023
Umsatz:	$59.87B
Bruttogewinn:	$43.89B (73.31 %)
EPS:	$0.140

FY	2023
Umsatz:	$59.87B
Bruttogewinn:	$43.89B (73.31 %)
EPS:	$0.140

FY	2022
Umsatz:	$59.28B
Bruttogewinn:	$41.87B (70.63 %)
EPS:	$5.73

FY	2021
Umsatz:	$48.70B
Bruttogewinn:	$35.08B (72.02 %)
EPS:	$5.16

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.690 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.770 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Merck & Co Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.64 - Stable (7.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00663	1970-06-02
Last Dividend	$0.770	2023-12-14
Next Dividend	$0	N/A
Payout Date	2024-01-08
Next Payout Date	N/A
# dividends	214	--
Total Paid Out	$52.58	--
Avg. Dividend % Per Year	2.07%	--
Score	5.72	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.64
Div. Directional Score	7.97	--

Next Divdend (Est)
(2024-07-08)

$0.776 Estimate 39.86 %

Dividend Stability

0.80 Good

Dividend Score

5.72

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1970	$0.0206	1.40%
1971	$0.0292	2.31%
1972	$0.0224	1.35%
1973	$0.0327	1.36%
1974	$0.0278	1.31%
1975	$0.0371	2.09%
1976	$0.0378	2.04%
1977	$0.0411	2.31%
1978	$0.0465	3.27%
1979	$0.0530	2.94%
1980	$0.0628	3.34%
1981	$0.0702	3.08%
1982	$0.0744	3.28%
1983	$0.0757	3.39%
1984	$0.0809	3.37%
1985	$0.0875	3.54%
1986	$0.106	2.90%
1987	$0.143	2.14%
1988	$0.208	2.38%
1989	$0.274	3.01%
1990	$0.321	2.57%
1991	$0.378	2.66%
1992	$0.458	1.73%
1993	$0.506	2.42%
1994	$0.554	3.29%
1995	$0.610	3.34%
1996	$0.706	2.30%
1997	$0.830	2.18%
1998	$0.946	1.84%
1999	$1.070	1.50%
2000	$1.202	1.86%
2001	$1.316	1.48%
2002	$1.356	2.38%
2003	$4.14	7.45%
2004	$1.432	3.19%
2005	$1.452	4.87%
2006	$1.452	4.65%
2007	$1.452	3.46%
2008	$1.452	2.65%
2009	$1.452	4.91%
2010	$1.452	4.11%
2011	$1.490	4.33%
2012	$1.613	4.41%
2013	$1.650	4.18%
2014	$1.689	3.58%
2015	$1.726	3.16%
2016	$1.765	3.52%
2017	$1.802	3.14%
2018	$1.899	3.54%
2019	$2.16	2.99%
2020	$2.37	2.69%
2021	$2.61	3.38%
2022	$2.80	3.64%
2023	$2.96	2.66%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0376	1.500	9.25	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0216	1.200	9.28	10.00	[0 - 0.3]
returnOnEquityTTM	0.0561	1.500	-0.488	-0.731	[0.1 - 1]
payoutRatioTTM	3.23	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.252	0.800	8.74	6.99	[1 - 3]
quickRatioTTM	0.710	0.800	-0.532	-0.425	[0.8 - 2.5]
cashRatioTTM	0.269	1.500	9.62	10.00	[0.2 - 2]
debtRatioTTM	0.331	-1.500	4.48	-6.72	[0 - 0.6]
interestCoverageTTM	8.10	1.000	8.11	8.11	[3 - 30]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.60	2.00	8.20	10.00	[0 - 20]
debtEquityRatioTTM	0.940	-1.500	6.24	-9.36	[0 - 2.5]
grossProfitMarginTTM	0.762	1.000	0.627	0.627	[0.2 - 0.8]
operatingProfitMarginTTM	0.119	1.000	9.61	9.61	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.368	1.000	9.07	9.07	[0.2 - 2]
assetTurnoverTTM	0.576	0.800	9.50	7.60	[0.5 - 2]
Total Score				11.29

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	141.07	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0561	2.50	-0.313	-0.731	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.60	2.00	8.80	10.00	[0 - 30]
dividendYielPercentageTTM	2.34	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	3.23	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-1.513	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.212	1.000	7.20	0	[0.1 - 0.5]
Total Score				4.64

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.